Ameritas Advisory Services’s Charles River Laboratories CRL Stock Holding History

Ameritas Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$2.82K	–	1166
2025 Q3	$2.82K	Sell	18 -1	-5%	-$159	﹤0.01%	1937
2025 Q2	$2.88K	Buy	+19	New	+$2.53K	﹤0.01%	2401
2023 Q2	–	Sell	-10	Closed	-$2.02K	–	941
2023 Q1	$2.02K	Buy	+10	New	+$2.27K	﹤0.01%	2385

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Ameritas Advisory Services's CRL Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 18 shares — an estimated $2.82K sold.

Ameritas Advisory Services first reported a position in CRL in Q1 2023 and held it in 3 quarters. The position peaked at $2.88K in Q2 2025. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

Ameritas Advisory Services reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
Ameritas Advisory Services sold 18 Charles River Laboratories shares in Q4 2025, an estimated $2.82K.
Ameritas Advisory Services first reported a position in Charles River Laboratories in Q1 2023 and held it in 3 quarters.
Ameritas Advisory Services's Charles River Laboratories position peaked at $2.88K in Q2 2025.
580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.